Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCWC.L Share News (CWC)

  • There is currently no data for CWC

Tuesday broker round-up UPDATE

Tue, 17th Dec 2013 08:14
Advanced Medical Solutions: Panmure Gordon downgrades from buy to hold with a target price of 102p.Antofagasta: Canaccord Genuity cuts target price from 1110p to 1035p, while staying with its buy recommendation.ASOS: Panmure Gordon increases target price from 5950p to 6126p, while downgrading from buy to hold.AstraZeneca: Deutsche Bank raises target price from 3425p to 3600p maintaining a hold recommendation.blur Group: Panmure Gordon ups target price from 677p to 690p and retains a buy recommendation.British American Tabacco: UBS reduces target price from 3850p to 3715p, while its buy recommendation remains unchanged.BTG: Deutsche Bank ups target price from 565p to 610p and reiterates its buy recommendation.Cable & Wireless Communications: Barclays shifts target price from 40p to 43p and retains an equal-weight rating.Daily Mail & General Trust: Westhouse Securities raises target price from 744p to 864p and maintains a neutral rating.Daisy Group: Barclays moves target price from 115p to 130p, but downgrades to underweight.Dixons Retail: Cantor Fitzgerald ups target price from 50p to 60p keeping a buy recommendation. Investec shifts target price from 60p to 62p retaining its buy recommendation.Europa Oil & Gas: Northland lowers target price from 14.3p to 10.1p leaving its buy recommendation unchanged.Experian: Jefferies reduces target price from 1200p to 1090p and keeps a hold recommendation.First Derivates: Panmure Gordon raises target price from 1191p to 1458p and keeps a buy recommendation.First Group: Goldman Sachs shifts target price from 135p to 140p and retains a buy recommendation.GlaxoSmithKline: Deutsche Bank reduces target price from 1800p to 1700p while downgrading to hold.Go-Ahead Group: Goldman Sachs increases target price from 1580p to 2100p and upgrades to a strong buy recommendation.Imagination Technologies: Barclays cuts target price from 250p to 185p and reiterates an equal-weight rating.Informa: Canaccord Genuity cuts target price from 600p to 568p downgrading from buy to hold.Inmarsat: Barclays takes target price from 705p to 740p and keeps an equal-weight rating.KCOM Group: Barclays moves target price from 100p to 115p retaining its overweight rating.Sepura: Westhouse Securities upgrades from add to buy with an unchanged target price of 160p.Stagecoach Group: Goldman Sachs downgrades to sell with a target price of 350p.Trinity Mirror: Panmure Gordon increases target price from 205p to 300p maintaining a buy recommendation.UBM: Deutsche Bank moves target price from 830p to 840p retaining a buy recommendation. Westhouse Securities reduces target price from 812p to 755p, while staying with its buy recommendation. Numis cuts target price from 732p to 710p and maintains a hold recommendation. Barclays reduces target price from 810p to 755p, while staying with its overweight rating.William Hill: Canaccord Genuity lowers target price from 425p to 408p leaving its hold recommendation unaltered.Wood Group: Canaccord Genuity cuts target price from 875p to 825p and reiterates a hold recommendation.Xcite Energy: Cantor Fitzgerald shapes target price from 168p to 167p leaving its buy recommendation unchanged.

Related News

AstraZeneca hails phase 3 trial results of inhibitor Ultomiris
23 mins ago

AstraZeneca hails phase 3 trial results of inhibitor Ultomiris

(Alliance News) - AstraZeneca PLC on Saturday announced new data on its kidney disease treatment Ultomiris.

IN BRIEF: British American Tobacco CEO buys GBP215,300 worth of shares
1 day ago

IN BRIEF: British American Tobacco CEO buys GBP215,300 worth of shares

British American Tobacco PLC - London-based cigarette and nicotine product maker - Chief Executive Tadeu Marroco and person closely associated Luciana...

PRESS: AstraZeneca warns it could delay Europe drug launches - FT
1 day ago

PRESS: AstraZeneca warns it could delay Europe drug launches - FT

(Alliance News) - AstraZeneca PLC could be forced to withhold new medicines from the UK and Europe unless governments pay more for innovative drugs, C...

CWC.L News

Cable & Wireless reports fall in half-year profit due to restructuring
7 Nov 2013

Cable & Wireless reports fall in half-year profit due to restructuring

- Pre-tax profit falls 36 per cent - Revenue declines three per cent - Cost cutting across the board Cable & Wireless Communications reported a 36 pe...

Cable & Wireless secures 20-year deal for Panama business
30 Oct 2013

Cable & Wireless secures 20-year deal for Panama business

Cable & Wireless Communications (CWC) announced on Wednesday that its Panama business has secured long-term access to several large blocks of radio sp...

C&W Comms pays $100 mln to extend Panama mobile licence
30 Oct 2013

C&W Comms pays $100 mln to extend Panama mobile licence

LONDON, Oct 30 (Reuters) - Cable & Wireless Communications has paid $100 million to Panama's government to extend its mobile licence by 20 years, all...

CWC hires former British Gas boss as new CEO
17 Oct 2013

CWC hires former British Gas boss as new CEO

- Chief Executive Tony Rice to leave at year-end - Former British Gas boss Phil Bentley named new CEO Cable & Wireless Communications (CWC) said Chie...

C&W Comms snaps up former British Gas boss Phil Bentley as CEO
17 Oct 2013

C&W Comms snaps up former British Gas boss Phil Bentley as CEO

LONDON, Oct 17 (Reuters) - British Gas' former head Phil Bentley will take the helm at Cable & Wireless Communications (CWC), realising his ambition t...